MAVILIO, Fulvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.909
AS - Asia 7.507
EU - Europa 6.463
SA - Sud America 1.011
AF - Africa 123
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 9
Totale 32.053
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.730
SG - Singapore 3.460
GB - Regno Unito 2.077
CN - Cina 1.776
HK - Hong Kong 1.232
RU - Federazione Russa 975
IT - Italia 899
BR - Brasile 848
SE - Svezia 739
DE - Germania 486
VN - Vietnam 307
FI - Finlandia 298
UA - Ucraina 249
BG - Bulgaria 215
TR - Turchia 192
FR - Francia 177
ID - Indonesia 106
KR - Corea 92
CA - Canada 81
IN - India 73
JP - Giappone 70
AR - Argentina 68
IE - Irlanda 56
NL - Olanda 53
MX - Messico 50
BE - Belgio 44
BD - Bangladesh 38
ZA - Sudafrica 34
PL - Polonia 30
AU - Australia 28
EC - Ecuador 26
AT - Austria 24
EG - Egitto 23
ES - Italia 23
IQ - Iraq 23
MA - Marocco 21
AE - Emirati Arabi Uniti 19
CO - Colombia 19
UZ - Uzbekistan 19
LT - Lituania 18
BZ - Belize 17
SI - Slovenia 15
CL - Cile 14
VE - Venezuela 14
IR - Iran 13
CH - Svizzera 11
PK - Pakistan 11
TN - Tunisia 11
LU - Lussemburgo 10
CZ - Repubblica Ceca 9
DK - Danimarca 9
KE - Kenya 9
PH - Filippine 9
GR - Grecia 8
RO - Romania 8
CR - Costa Rica 7
PE - Perù 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
JO - Giordania 6
KZ - Kazakistan 6
MY - Malesia 6
PA - Panama 6
PY - Paraguay 6
SA - Arabia Saudita 6
TW - Taiwan 6
AZ - Azerbaigian 5
NG - Nigeria 5
PT - Portogallo 5
AL - Albania 4
BY - Bielorussia 4
DZ - Algeria 4
EU - Europa 4
IL - Israele 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
CI - Costa d'Avorio 3
ET - Etiopia 3
GH - Ghana 3
KG - Kirghizistan 3
MD - Moldavia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 32.033
Salva come PNG Salva come JPEG
Città #
Singapore 2.645
Fairfield 2.045
Santa Clara 1.860
Ashburn 1.344
Hong Kong 1.226
Southend 1.212
Woodbridge 1.088
Chandler 952
Houston 936
Wilmington 668
Seattle 657
Cambridge 623
Ann Arbor 596
London 550
Jacksonville 503
Nyköping 455
Hefei 402
Dearborn 387
Beijing 370
Chicago 312
Los Angeles 290
San Diego 263
Modena 240
Princeton 219
Sofia 213
Helsinki 210
The Dalles 176
Salt Lake City 134
New York 122
Bremen 119
Buffalo 115
Eugene 102
Ho Chi Minh City 89
Jakarta 88
Seoul 88
Shanghai 88
Moscow 83
Council Bluffs 79
Elk Grove Village 75
Izmir 73
São Paulo 65
San Jose 63
Des Moines 62
Milan 62
Hanoi 57
Tampa 57
Dublin 56
Dallas 54
Dong Ket 52
Brussels 43
Redwood City 38
Redondo Beach 37
San Francisco 36
Norwalk 35
Columbus 34
Frankfurt am Main 32
Tokyo 31
Boardman 30
Rio de Janeiro 30
Atlanta 29
Belo Horizonte 29
Bonndorf 29
Lancaster 29
Phoenix 29
Brooklyn 27
Falls Church 27
Guangzhou 26
Hounslow 26
Munich 26
Rome 26
Sterling 26
Toronto 24
Nuremberg 23
Paris 23
Kilburn 22
Montreal 21
Warsaw 21
Mexico City 19
Nanjing 18
Belize City 17
Cairo 17
Dulles 17
Hangzhou 17
Melbourne 17
Brasília 16
Kent 16
Kocaeli 16
Tashkent 16
Denver 15
Wuhan 15
Boston 14
Camden 14
Detroit 14
Charlotte 13
Dhaka 13
Haiphong 13
Istanbul 13
Las Vegas 13
Philadelphia 13
Pittsburgh 13
Totale 23.383
Salva come PNG Salva come JPEG
Nome #
Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions 874
High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors 370
PPARδ is a ligand-dependent negative regulator of Vitamin D3-induced monocyte differentiation 369
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 368
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 361
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 332
Comprehensive genomic access to vector integration in clinical gene therapy 327
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 312
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 310
Site-specific integration by the adeno-associated virus rep protein 303
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 298
Mechanisms of retroviral integration and mutagenesis 297
Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation 295
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 290
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease 284
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 284
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 282
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts 279
Definition of the transcriptional activation domains of three human HOX proteins depends on the DNA-Binding context 278
A single epidermal stem cell strategy for safe ex vivo gene therapy 271
Medicina rigenerativa e nuove frontiere terapeutiche 269
Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptor 268
Nuclear architecture dictates HIV-1 integration site selection 268
Gene therapy approaches for epidermolysis bullosa 263
Site-specific integration into the human genome: Ready for clinical application? 262
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 262
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 260
Tracking gene-modified T cells in vivo. 258
Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells 256
C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. 255
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 255
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors 252
Gene therapy in combination with tissue engineering to treat epidermolysis bullosa 248
Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors 248
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 244
Gene therapy of skin adhesion disorders (mini review) 244
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human b-globin locus 240
T Lymphocytes transduced with a lentiviral vector expressing F12-Vif are protected from HIV-1 infection in an APOBEC3G-independent manner 238
Muscle-derived hematopoietic stem cells are hematopoietic in origin 235
Stem cell plasticity: time for a reappraisal? 234
Defining the lentiviral integrome in human hematopoietic cells 234
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa 233
Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients 233
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 228
Long-term engraftment of single genetically modified epidermal stem cell-derived clones enables safety pre-assessment of human cutaneous gene therapy 227
Gene therapy of inherited skin adhesion disorders: a critical overview 225
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 225
Functional dissection of a transcriptionally active, target specific Hox/Pbx complex. 224
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy 222
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID 222
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 221
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy 221
Bone-marrow transplantation - Failure to correct murine muscular dystrophy 218
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 218
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy? 217
Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells 217
Towards a gene therapy clinical trial for epidermolysis bullosa 213
Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning 212
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 211
Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy 211
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 210
Transcriptional targeting of lentiviral vectors by LTR enhancer replacement 208
Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein 206
The recruitment of SOX/OCT complexes and the differential activity of HOXA1 and HOXB1 modulate the Hoxb1 auto-regulatory enhancer function 200
High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors 198
Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? 197
Clonal analysis of stably transduced human epidermal stem cells in culture. 197
Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements 195
Interactions between Retroviruses and the Host Cell Genome 195
Towards the correction of genetic defect in corneal keratinocytes from patient with macular corneal Dystrophy type II 193
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 191
Safety of retroviral gene marking with a truncated NGF receptor 189
Toward gene therapy of junctional epidermolysis bullosa (JEB) 187
Translating the genomics revolution: The need for an international gene therapy consortium for monogenic diseases 187
Gene therapies need new development models 182
Repairing without cutting: A safer alternative to gene correction? 182
Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells 181
RD2-molpack-chim3, a packaging cell line for stable production of lentiviral vectors for Anti-HIV gene therapy 179
An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype 179
Genetic modification of somatic stem cells. The progress, problems and prospects of a new therapeutic technology 178
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 178
Perspectives on Best Practices for Gene Therapy Programs 173
Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells 172
The future of gene therapy 170
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study 167
Epithelial stem cells in corneal regeneration and epidermal gene therapy 165
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult 164
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome 163
Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors 161
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia 158
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs 156
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency 153
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 152
Developing gene and cell therapies for rare diseases: An opportunity for synergy between academia and industry 151
Gene therapy: back on track? 145
A human homoeo box gene specifically expressed in spinal cord during embryonic development 145
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy 144
Differential and stage-related expression in embryonic tissues of a new human homoeobox gene 142
Alternative splicing caused by lentiviral integration in the human genome 140
A novel homeo-domain protein, prep 1, forms a regulatory complex with pbx proteins in vivo 140
Totale 23.248
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.176
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.157 0 0 0 0 0 317 215 342 322 439 314 208
2021/20223.677 389 358 213 187 83 353 166 190 403 379 608 348
2022/20232.948 356 286 243 229 384 424 46 287 398 32 141 122
2023/20242.759 82 103 93 168 345 235 253 678 144 154 172 332
2024/20256.512 187 55 68 494 1.324 934 338 365 789 471 710 777
2025/20266.920 701 445 866 1.380 2.794 734 0 0 0 0 0 0
Totale 32.385